B. Lacour, A. Guyot-goubin, S. Guissou, S. Bellec, E. Désandes et al., Incidence of childhood cancer in France: National Children Cancer Registries, Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP, vol.19, issue.3, pp.173-81, 2000.

E. Ek, C. R. Dass, and P. Choong, Commonly used mouse models of osteosarcoma, Crit Rev Oncol Hematol, vol.60, issue.1, pp.1-8, 2006.

G. Ottaviani and N. Jaffe, The epidemiology of osteosarcoma, Cancer Treat Res, vol.152, pp.3-13, 2009.

J. Thariat, M. Julieron, A. Brouchet, A. Italiano, T. Schouman et al., Osteosarcomas of the mandible: are they different from other tumor sites?, Crit Rev Oncol Hematol, vol.82, issue.3, pp.280-95, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00638903

H. Van-den-berg, W. H. Schreuder, and J. De-lange, Osteosarcoma: a comparison of Jaw versus Nonjaw localizations and review of the literature, Sarcoma, p.316123, 2013.

J. Thariat, T. Schouman, A. Brouchet, J. Sarini, R. C. Miller et al., Osteosarcomas of the mandible: multidisciplinary management of a rare tumor of the young adult a cooperative study of the GSF-GETO, Rare Cancer Network, GETTEC/REFCOR and SFCE, Ann Oncol Off J Eur Soc Med Oncol ESMO, vol.24, issue.3, pp.824-855, 2013.

E. H. Nissanka, E. Amaratunge, and W. M. Tilakaratne, Clinicopathological analysis of osteosarcoma of jaw bones, Oral Dis, vol.13, issue.1, pp.82-89, 2007.

F. Wagner, B. M. Holzapfel, L. Thibaudeau, M. Straub, M. Ling et al., A validated preclinical animal model for primary bone tumor research, J Bone Joint Surg Am, vol.98, issue.11, pp.916-941, 2016.

A. Luetke, P. A. Meyers, I. Lewis, and H. Juergens, Osteosarcoma treatmentwhere do we stand? A state of the art review, Cancer Treat Rev, vol.40, issue.4, pp.523-555, 2014.

V. Crenn, K. Biteau, J. Amiaud, C. Dumars, R. Guiho et al., Bone microenvironment has an influence on the histological response of osteosarcoma to chemotherapy: retrospective analysis and preclinical modeling, Am J Cancer Res, vol.7, issue.11, pp.2333-2382, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01680800

M. Granowski-lecornu, S. Chuang, L. B. Kaban, and M. August, Osteosarcoma of the jaws: factors influencing prognosis, J Oral Maxillofac Surg Off J Am Assoc Oral Maxillofac Surg, vol.69, issue.9, pp.2368-75, 2011.

W. Lu, T. Chao, C. Ruiqi, S. Juan, and L. Zhihong, Patient-derived xenograft models in musculoskeletal malignancies, J Transl Med, vol.16, p.107, 2018.

M. V. Guijarro, S. C. Ghivizzani, and C. P. Gibbs, Animal models in osteosarcoma, Front Oncol, vol.4, p.189, 2014.

B. Wadayama, J. Toguchida, T. Shimizu, K. Ishizaki, M. S. Sasaki et al., Mutation spectrum of the retinoblastoma gene in osteosarcomas, Cancer Res, vol.54, issue.11, pp.3042-3050, 1994.

J. Toguchida, T. Yamaguchi, B. Ritchie, R. L. Beauchamp, S. H. Dayton et al., Mutation spectrum of the p53 gene in bone and soft tissue sarcomas, Cancer Res, vol.52, issue.22, pp.6194-6203, 1992.

C. W. Miller, A. Aslo, A. Won, M. Tan, B. Lampkin et al., Alterations of the p53, Rb and MDM2 genes in osteosarcoma, J Cancer Res Clin Oncol, vol.122, issue.9, pp.559-65, 1996.

R. Rubio, A. Abarrategi, J. Garcia-castro, L. Martinez-cruzado, C. Suarez et al., Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells, Stem Cells Dayt Ohio, vol.32, issue.5, pp.1136-1184, 2014.

A. Alfranca, L. Martinez-cruzado, J. Tornin, A. Abarrategi, T. Amaral et al., Bone microenvironment signals in osteosarcoma development, Cell Mol Life Sci CMLS, vol.72, issue.16, pp.3097-113, 2015.

Ö. Uluçkan, A. Segaliny, S. Botter, J. M. Santiago, and A. J. Mutsaers, Preclinical mouse models of osteosarcoma, BoneKEy Rep, vol.4, p.670, 2015.

R. J. Lee, A. Arshi, H. C. Schwartz, and R. E. Christensen, Characteristics and prognostic factors of osteosarcoma of the jaws: a retrospective cohort study, JAMA Otolaryngol Head Neck Surg, vol.141, issue.5, pp.470-477, 2015.

B. Ory, M. Heymann, A. Kamijo, F. Gouin, D. Heymann et al., Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice, Cancer, vol.104, issue.11, pp.2522-2531, 2005.

C. Kilkenny, W. J. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research, PLoS Biol, vol.8, issue.6, p.1000412, 2010.

K. A. Janeway and C. R. Walkley, Modeling human osteosarcoma in the mouse: from bedside to bench, Bone, vol.47, issue.5, pp.859-65, 2010.

M. K. Walia, W. Castillo-tandazo, A. J. Mutsaers, T. J. Martin, and C. R. Walkley, Murine models of osteosarcoma: a piece of the translational puzzle, J Cell Biochem, vol.119, pp.4241-50, 2017.

C. Blattmann, M. Thiemann, A. Stenzinger, E. K. Roth, A. Dittmar et al., Establishment of a patient-derived orthotopic osteosarcoma mouse model, J Transl Med, vol.13, p.136, 2015.

A. J. Mutsaers, A. Ng, E. K. Baker, M. R. Russell, A. M. Chalk et al., Modeling distinct osteosarcoma subtypes in vivo using Cre:lox and lineagerestricted transgenic shRNA, Bone, vol.55, issue.1, pp.166-78, 2013.

K. B. Jones, Osteosarcomagenesis: modeling cancer initiation in the mouse, Sarcoma, p.694136, 2011.

. Bertin, 17:56 ? fast, convenient online submission ? thorough peer review by experienced researchers in your field ? rapid publication on acceptance ? support for research data, including large and complex data types ? gold Open Access which fosters wider collaboration and increased citations maximum visibility for your research: over 100M website views per year ? At BMC, J Transl Med, 2019.

Y. Lai, X. Wei, S. Lin, L. Qin, L. Cheng et al., Current status and perspectives of patient-derived xenograft models in cancer research, J Hematol OncolJ Hematol Oncol, vol.10, issue.1, p.106, 2017.

J. Stebbing, K. Paz, G. K. Schwartz, L. H. Wexler, R. Maki et al., Patient-derived xenografts for individualized care in advanced sarcoma, Cancer, vol.120, issue.13, pp.2006-2021, 2014.

P. J. Houghton, C. L. Morton, C. Tucker, D. Payne, E. Favours et al., The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer, vol.49, pp.928-968, 2007.

G. Bousquet and A. Janin, Patient-derived xenograft: an adjuvant technology for the treatment of metastatic disease, Pathobiol J Immunopathol Mol Cell Biol, vol.83, issue.4, pp.170-176, 2016.

M. J. Joliat, S. Umeda, B. L. Lyons, M. A. Lynes, and L. D. Shultz, Establishment and characterization of a new osteogenic cell line (MOS-J) from a spontaneous C57BL/6J mouse osteosarcoma, Vivo Athens Greece, vol.16, issue.4, pp.223-231, 2002.

C. R. Dass, E. Ek, and P. Choong, Human xenograft osteosarcoma models with spontaneous metastasis in mice: clinical relevance and applicability for drug testing, J Cancer Res Clin Oncol, vol.133, issue.3, pp.193-201, 2007.

S. N. Jawad and B. H. Abdullah, Proliferative, apoptotic and angiogenic potentials in jaws and long bones osteosarcomas: a comparative immunohistochemical study, J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol, vol.39, issue.9, pp.681-687, 2010.

W. Chen, H. Feng, and H. Li, Expression and significance of hypoxemia-inducible factor-1alpha in osteosarcoma of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, vol.106, pp.254-261, 2008.